Use of 1- (2-chloroethyl) -1-nitroso-3- (2-hydroxyethyl) urea for the treatment of pancreatic carcinomas, soft tissue sarcomas, testicular tumors, lymphomas, thymomas, Wilms tumors, kidney carcinomas, melanomas, lung tumors, intracerebral metastases, tumors in Head and neck area, and breast cancer
DE10260618A1
Tumor-inhibiting fused azepinone derivatives
DE10226592A1
Anti-tumor platinum (II) oxalato complexes
DE10218312C1
New bis-(amino-hydrocarbyloxy or N-containing heterocyclyloxy)-silicon compounds, useful as anticancer agents
DE10202468A1
Pteridine derivatives, process for their preparation and their use
DE10141528A1
Platinum (II) and platinum (IV) complexes and their use
DE10138561A1
Tumor-inhibiting cerium compounds and their use
DE10138538A1
Anti-tumor lanthanum compounds
DE10116527A1
Tumor-inhibiting gallium compounds, their use as a medicament and a medicament containing them
DE10114106C1
New quaternary ammonio-substituted orthosilicate esters, useful as anticancer agents having strong activity against a broad spectrum of human tumor cell lines
DE10114222C1
Tropolonato-silicon derivatives useful for the prevention and treatment of cancers
DE10113185A1
Composition containing a gallium (III) complex and a therapeutically active platinum complex
DE10103565A1
Compositions containing a ruthenium (III) complex and a heterocycle
DE19955576A1
Transfer compounds, their preparation and their use
